Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib

被引：0
|
作者：
Houssam Oweini
Zaher K. Otrock
Rami A. R. Mahfouz
Ali Bazarbachi
机构：
[1] American University of Beirut Medical Center,Department of Internal Medicine
[2] American University of Beirut Medical Center,Department of Pathology and Laboratory Medicine
[3] American University of Beirut Medical Center,Bone Marrow Transplantation Program, Department of Medicine
来源：
Archives of Gynecology and Obstetrics | 2011年 / 283卷
关键词：
Chronic myeloid leukemia; Dasatinib; Pregnancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dasatinib is a highly potent Bcr-Abl inhibitor that is approved for the treatment of imatinib-resistant or -intolerant chronic myeloid leukemia (CML). The potential effects of dasatinib on sperm counts, sperm function, and fertility have not been studied yet. There is only one report in the medical literature of successful pregnancies while patients were taking dasatinib, thus making our case the second report. Here, we present the case of a 38-year-old man who conceived a healthy baby while on dasatinib therapy.
引用
收藏
页码：133 / 134
页数：1
相关论文
共 50 条
  • [21] Successful Pregnancy in a Patient with Chronic Myeloid Leukemia under Treatment with Imatinib
    Tsuzuki, Motohiro
    Inaguma, Youko
    Handa, Kousuke
    Hasegawa, Akio
    Yamamoto, Yukiya
    Watanabe, Masato
    Mizuta, Syuichi
    Maruyama, Fumio
    Okamoto, Masataka
    Emi, Nobuhiko
    INTERNAL MEDICINE, 2009, 48 (16) : 1433 - 1435
  • [22] Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia
    Rios, Silvina J.
    Martinez-Montesinos, Lorena
    Aroca, Cristina
    Teruel-Montoya, Raul
    Ferrer-Marin, Francisca
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (10) : 2473 - 2476
  • [23] Successful pregnancy outcome in a patient of chronic myeloid leukemia without therapy
    Roychowdhury J.
    Bhattacharyya M.
    Kumar K.A.
    Panfalia M.
    The Journal of Obstetrics and Gynecology of India, 2011, 61 (5) : 565 - 566
  • [24] Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia
    Serpa, Mariana
    Bendit, Israel
    Seguro, Fernanda
    Xavier, Flavia
    Cavalcante, Marcela
    Steinbaum, Daniel
    Nardinelli, Luciana
    Aldred, Vera Lucia
    de Paula, Henrique Moura
    Dorlhiac-Llacer, Pedro Enrique
    ACTA HAEMATOLOGICA, 2010, 124 (02) : 105 - 109
  • [25] Dasatinib Dose Management for the Treatment of Chronic Myeloid Leukemia
    Talpaz, Moshe
    Saglio, Giuseppe
    Atallah, Ehab
    Rousselot, Philippe
    CANCER, 2018, 124 (08) : 1660 - 1672
  • [26] Dasatinib-Induced Chylothorax In Chronic Myeloid Leukemia
    Baloch, Z. A. Qutrio
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia
    Lima, Lisa M.
    Arellano, Martha
    Holloway, Stacie
    Shepard, Marian
    McMillan, Stephanie
    Khoury, Hanna Jean
    JOURNAL OF BLOOD MEDICINE, 2010, 1 : 221 - 225
  • [28] Dasatinib in chronic myeloid leukemia: A limited Indian experience
    Sharma, Atul
    Bahl, Ankur
    Raina, Vinod
    Kumar, Lalit
    Gupta, Ritu
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (04) : 375 - 379
  • [29] Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
    Ramchandren, Radhakrishnan
    Schiffer, Charles A.
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 205 - 214
  • [30] Palmoplantar Keratoderma in a Patient of Chronic Myeloid Leukemia on Dasatinib
    Gupta, Priyansh
    Sangwan, Priyanka
    Das, Prabodha Kumar
    Sethy, Madhusmita
    Behera, Biswanath
    Thakur, Vishal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (04) : 710 - 714
12345